Suppr超能文献

非小细胞肺癌中转移性和非转移性纵隔淋巴结的大小

Size of metastatic and nonmetastatic mediastinal lymph nodes in non-small cell lung cancer.

作者信息

Ikeda Koei, Nomori Hiroaki, Mori Takeshi, Kobayashi Hironori, Iwatani Kazunori, Yoshimoto Kentaro

机构信息

Department of Thoracic Surgery, Graduate School of Medicine, Kumamoto University, Kumamoto, Japan.

出版信息

J Thorac Oncol. 2006 Nov;1(9):949-52.

Abstract

OBJECTIVE

To determine the optimum selection of mediastinal lymph nodes for biopsy in non-small cell lung cancer (NSCLC), lymph nodes with or without metastasis at each mediastinal station were ranked in size in patients with pathological N2 disease.

METHODS

Twenty-five NSCLC patients with pathological N2 disease who underwent pulmonary resection with complete mediastinal lymph node clearance were examined. Of 114 mediastinal lymph node stations dissected, 47 had metastases and 67 did not. The sizes of 259 nodes in the 47 positive lymph node stations were measured. Of these 259 nodes, 137 had metastases and 122 did not. The short- and long-axis diameters of the 259 lymph nodes were ranked in each lymph node station.

RESULTS

Mean short- and long-axis diameters of lymph nodes with metastases were significantly greater than those without (p < 0.001). In 47 metastatic lymph node stations, the short- and long-axis diameters were greatest in a metastatic node in 44 (94%) and 42 (89%) respectively, whereas in the remaining 3 (6%) and 5 (11%), the second largest but not the largest node was positive. None of the largest lymph nodes with metastasis were smaller than the second largest lymph node at each station. Four of the 10 patients with adenocarcinoma (40%) had metastasis in the second largest but not in the largest node measured by long-axis diameter, a significant difference from one in eight (12.5%) among the squamous cell carcinoma cases (p = 0.04).

CONCLUSION

For mediastinal lymph node biopsy, both the largest and the second largest node at each station should be sampled, especially in adenocarcinoma. If only the largest lymph node is selected, false-negative results will occur at a rate of about 10%.

摘要

目的

为确定非小细胞肺癌(NSCLC)纵隔淋巴结活检的最佳选择,对病理N2期疾病患者各纵隔区域有或无转移的淋巴结按大小进行排序。

方法

对25例行肺切除并完整清扫纵隔淋巴结的病理N2期NSCLC患者进行检查。在清扫的114个纵隔淋巴结区域中,47个有转移,67个无转移。测量了47个阳性淋巴结区域中259个淋巴结的大小。在这259个淋巴结中,137个有转移,122个无转移。对每个淋巴结区域内259个淋巴结的短径和长径进行排序。

结果

有转移的淋巴结的平均短径和长径显著大于无转移的淋巴结(p<0.001)。在47个有转移的淋巴结区域中,短径和长径最大的淋巴结分别在44个(94%)和42个(89%)区域为转移淋巴结,而在其余3个(6%)和5个(11%)区域,第二大而非最大的淋巴结为阳性。每个区域最大的有转移淋巴结均不小于第二大淋巴结。10例腺癌患者中有4例(40%)长径测量显示转移发生在第二大而非最大的淋巴结,与鳞状细胞癌患者中八分之一(12.5%)的比例有显著差异(p=0.04)。

结论

对于纵隔淋巴结活检,每个区域的最大和第二大淋巴结均应取样,尤其是腺癌。若仅选择最大的淋巴结,假阴性结果发生率约为10%。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验